# Advisor Review - Advisor 3/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-29T22:19:16.101404
**Response ID:** resp_038aacb1b87a4df900697bcd98f06c8196aa59aa880ac56b31
**Tokens:** 41180 in / 6609 out
**Response SHA256:** b3d9db3e0077f85a

---

No fatal errors detected in the four required categories.

### 1) Data–Design Alignment (Critical)
- **Treatment timing vs. data coverage:** Full-exposure treatment years run **2013–2021** (Table 2), and the LAUS outcome panel covers **2007–2023** (N = 50×17 = 850). No treatment year exceeds the outcome data’s max year.
- **Post-treatment observations by cohort:** Every cohort has post-treatment observations in the outcome data (e.g., 2021 cohort has 2021–2023). Cohort post-years reported in Table 4 are arithmetically consistent with 2007–2023.
- **Treatment definition consistency:** The “full-exposure year” definition is used consistently across the narrative, Table 2, and the event-time definition in figures/tables (and the anticipation window discussion is consistent with that coding).

### 2) Regression Sanity (Critical)
- I scanned the main and appendix tables shown (Tables 1–20). Coefficients and SEs are in plausible ranges for log employment and percentage-point unemployment outcomes.
- No impossible outputs (negative SEs, NA/NaN/Inf, absurd magnitudes) appear.

### 3) Completeness (Critical)
- Regression-style tables report **standard errors** and **sample sizes (N)** where appropriate (e.g., Table 3, Table 10, Table 18).
- No placeholders (TBD/TODO/XXX/NA cells) appear in the displayed tables/figures.
- Cross-references in the text to figures/tables that are shown here appear to exist (e.g., Figures 2–9; Tables 6–8, 15, 18–20).

### 4) Internal Consistency (Critical)
- Key headline numbers in the abstract match Table 3 (e.g., **ATT log employment = 0.0036 (0.0079)**; **unemp = −0.242 (0.293)**).
- Panel dimensions are consistent throughout (850 total state-years; 782 ever-treated, 68 never-treated).
- Cohort counts and timing in Figure 1/Table 2 align with the cohort-size statements in the text.

ADVISOR VERDICT: PASS